Prenetics Global Ltd

NASDAQ:PRE USA Diagnostics & Research
Market Cap
$316.08 Million
Market Cap Rank
#14474 Global
#5811 in USA
Share Price
$20.73
Change (1 day)
-4.60%
52-Week Range
$3.29 - $21.97
All Time High
$120.81
About

Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more

Market Cap & Net Worth: Prenetics Global Ltd (PRE)

Prenetics Global Ltd (NASDAQ:PRE) has a market capitalization of $316.08 Million ($316.08 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #14474 globally and #5811 in its home market, demonstrating a 1.17% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Prenetics Global Ltd's stock price $20.73 by its total outstanding shares 15247465 (15.25 Million).

Prenetics Global Ltd Market Cap History: 2021 to 2026

Prenetics Global Ltd's market capitalization history from 2021 to 2026. Data shows change from $1.76 Billion to $316.08 Million (-30.91% CAGR).

Index Memberships

Prenetics Global Ltd is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NASDAQ Health Care
IXHC
$2.24 Trillion 0.01% #385 of 976
NASDAQ Composite
IXIC
$33.39 Trillion 0.00% #1376 of 3165

Weight: Prenetics Global Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Prenetics Global Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Prenetics Global Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

2.89x

Prenetics Global Ltd's market cap is 2.89 times its annual revenue

Industry average:
0.69x
Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2021 $1.76 Billion $12.53 Million -$174.01 Million 140.05x N/A
2022 $457.42 Million $13.16 Million -$190.45 Million 34.75x N/A
2023 $90.11 Million $21.74 Million -$62.72 Million 4.14x N/A
2024 $88.44 Million $30.62 Million -$46.30 Million 2.89x N/A

Competitor Companies of PRE by Market Capitalization

Companies near Prenetics Global Ltd in the global market cap rankings as of March 18, 2026.

Key companies related to Prenetics Global Ltd by market ranking:

  • Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
  • Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
  • IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
  • Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#90 Thermo Fisher Scientific Inc NYSE:TMO $177.20 Billion $472.71
#151 Danaher Corporation NYSE:DHR $122.79 Billion $195.21
#466 IDEXX Laboratories Inc NASDAQ:IDXX $46.38 Billion $586.98
#511 Lonza Group Ltd PINK:LZAGF $41.73 Billion $596.13

Prenetics Global Ltd Historical Marketcap From 2021 to 2026

Between 2021 and today, Prenetics Global Ltd's market cap moved from $1.76 Billion to $ 316.08 Million, with a yearly change of -30.91%.

Year Market Cap Change (%)
2026 $316.08 Million +31.62%
2025 $240.15 Million +171.55%
2024 $88.44 Million -1.86%
2023 $90.11 Million -80.30%
2022 $457.42 Million -73.94%
2021 $1.76 Billion --

End of Day Market Cap According to Different Sources

On Mar 18th, 2026 the market cap of Prenetics Global Ltd was reported to be:

Source Market Cap
Yahoo Finance $316.08 Million USD
MoneyControl $316.08 Million USD
MarketWatch $316.08 Million USD
marketcap.company $316.08 Million USD
Reuters $316.08 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.